Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A novel approach to assess gastrointestinal adverse effects of opioids

Next Previous
X
Search
Trial Profile

A novel approach to assess gastrointestinal adverse effects of opioids

Status: Completed
Phase of Trial: Phase II/III

Latest Information Update: 31 Oct 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Oxycodone/naloxone (Primary) ; Oxycodone
  • Indications Intestinal disorders
  • Focus Therapeutic Use

    • Most Recent Events

    • 14 Oct 2022 Results comparing regional transit times in patients with CP to those in healthy controls, and investigating whether they were associated with diabetes mellitus, exocrine dysfunction, opioid treatment or quality of life, published in the Medicine
    • 10 Oct 2017 New trial record
    • 06 Oct 2017 Results published in the Digestive Diseases and Sciences

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top